Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: J Immunol. 2011 Aug 5;187(5):2155–2161. doi: 10.4049/jimmunol.1003235

Figure 1.

Figure 1

IL-17 production by healthy donor and burn patient PBMC stimulated with CAg. Blood samples were individually collected from burn patients (# 1 to # 26) and healthy donors (#1 to #5) (see Table I). A. PBMC (2 × 106 cells/ml), derived from 3 burn patients (#1, #12, and #17) and 3 healthy donors (#1, #2 and #3), were stimulated with CAg in vitro. Culture fluids harvested 1 to 5 days after stimulation were assayed for IL-17. B and C. A total of 31 PBMC samples (26 burn patient PBMC and 5 healthy donor PBMC) were stimulated with CAg (B) or anti-CD3 mAb (C). Culture fluids harvested 3 days after stimulation were assayed for IL-17.